These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4448804)

  • 21. Hypercalciuria in sarcoidosis.
    Lebacq EG; Henrion J; Mayeur S
    Z Erkr Atmungsorgane; 1977 Aug; 149(2):219-23. PubMed ID: 610100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of phosphate in recurrent calcium lithiasis. A current view].
    Reina Ruiz MC; Conde Sánchez JM; Domínguez Domínguez M; Espinosa Olmedo J; García Pérez M
    Arch Esp Urol; 2001 Nov; 54(9):1029-35. PubMed ID: 11789360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanisms of hypercalciuria are unnecessary for treatment of recurrent renal calcium stone formers.
    Peacock M
    Contrib Nephrol; 1982; 33():152-62. PubMed ID: 6288323
    [No Abstract]   [Full Text] [Related]  

  • 24. [Importance of dietary sodium in the hypercalciuria syndrome and nephrolithiasis].
    Gołabek B; Słownik M; Grabowski M
    Pol Merkur Lekarski; 2000 Apr; 8(46):174-7. PubMed ID: 10897599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium oxalate stone disease: effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria.
    Hautmann R; Hering FJ; Lutzeyer W
    J Urol; 1978 Dec; 120(6):712-5. PubMed ID: 731812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Own experiences with phosphate therapy of urinary calculi].
    Kollwitz AA; Brauer R; Kracht H
    Urologe; 1967; 6(4):228-30. PubMed ID: 5589321
    [No Abstract]   [Full Text] [Related]  

  • 27. Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"?
    Preminger GM
    Semin Urol; 1994 Feb; 12(1):51-64. PubMed ID: 8197337
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():239-52. PubMed ID: 6938001
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis and management of hypercalciuric nephrolithiasis.
    Breslau NA
    Miner Electrolyte Metab; 1994; 20(6):328-39. PubMed ID: 7783695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Idiopathic hypercalciuria--its pitfalls and therapy].
    Kocián J
    Vnitr Lek; 1978 Nov; 24(11):1070-6. PubMed ID: 716252
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of renal lithogenesis. (VIII) Therapeutic response of hyperoxaluric patients after 5 years' treatment].
    Ruiz-Marcellán FJ; Bernshtam J; Pinto B
    Rev Clin Esp; 1983 Jan; 168(1):9-12. PubMed ID: 6844687
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of oral phosphate therapy on the course of urolithiasis in patients with calcium-containing calculi].
    Horn HD
    Urologe; 1967; 6(4):223-8. PubMed ID: 5589320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hydrochlorothiazide and chlorthalidone in the treatment of patients with calcium-phosphate disorders].
    Sawicki A; Soszyński P
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):993-7. PubMed ID: 6504725
    [No Abstract]   [Full Text] [Related]  

  • 35. The incidence, investigation and treatment of idiopathic hypercalciuria.
    Rose GA; Harrison AR
    Br J Urol; 1974 Jun; 46(3):261-74. PubMed ID: 4846153
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of osteoporosis with phosphate.
    Goldsmith RS
    Semin Drug Treat; 1972; 2(1):35-7. PubMed ID: 4558757
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary calcium and magnesium variations during sodium cellulose phosphate treatment.
    Trinchieri A; Mandressi A; Zanetti G; Patelli E; Donghi G; Rocco F
    Contrib Nephrol; 1984; 37():41-4. PubMed ID: 6713878
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical aspects of calcium metabolism.
    Harrison AR
    Trans Med Soc Lond; 1970; 86():55-62. PubMed ID: 5494698
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of the administration of sodium phosphate cellulose as medical treatment of primary hyperparathyroidism].
    Rapado A; Castrillo JM; Esbrit P; Barranco L; de la Piedra C; Traba ML
    Med Clin (Barc); 1984 Apr; 82(16):702-4. PubMed ID: 6738181
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.